Internal Medicine, Hematology & Oncology · Vista, CA
NPI
1801992839
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
910 Sycamore Ave, Suite 270
Vista, CA, 92081
Phone (760) 598-1700
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.4M
87,336 services
Medicare patients, 2024
446
Average age 74
Drug cost, 2024
$3.0M
618 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Derek A Helton was code J1439 (injection, ferric carboxymaltose, 1 mg), 18,750 times for 14 patients. In total Derek A Helton billed 87,336 services in 107 codes, and Medicare paid $1.4M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-05-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 18,750 | 14 | $0.88 | $17K |
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 6,930 | 12 | $8.67 | $60K |
| J0897 Injection, denosumab, 1 mg | Office | 4,320 | 26 | $20.68 | $89K |
| 99215 Office E&M - Established | Office | 638 | 210 | $128.02 | $82K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 619 | 191 | $12.77 | $7,907 |
| J7050 Infusion, normal saline solution, 250 cc | Office | 401 | 86 | $0.52 | $208 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 332 | 11 | $0.09 | $29.89 |
| 96372 Injection Administration | Office | 224 | 73 | $12.34 | $2,765 |
| 96523 Chemotherapy | Office | 177 | 54 | $22.68 | $4,014 |
| 96375 Injection Administration | Office | 140 | 27 | $13.67 | $1,914 |
| 96365 Intravenous Infusion, Hydration | Office | 136 | 60 | $56.70 | $7,711 |
| J3489 Injection, zoledronic acid, 1 mg | Office | 134 | 20 | $5.07 | $680 |
| J7060 5% dextrose/water (500 ml = 1 unit) | Office | 122 | 21 | $1.42 | $173 |
| 96360 Intravenous Infusion, Hydration | Office | 118 | 29 | $29.18 | $3,444 |
| J7030 Infusion, normal saline solution , 1000 cc | Office | 117 | 27 | $2.08 | $243 |
By year: 2022 $434K for 37,884 services; 2023 $959K for 87,279 services; 2024 $1.4M for 87,336 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 34 | 18 | $7.61 | $259 |
| 80053 Clinical Chemistry | 12 | 11 | $10.35 | $124 |
Medicare prescription drug claims, 2024
In 2024, the drug Derek A Helton prescribed most often to Medicare patients was Hydroxyurea, with 50 prescriptions and refills. In total Derek A Helton wrote 618 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxyurea Generic | 50 | 123 | 12 | $1,728 |
| Erleada Apalutamide | 46 | 51 | Under 11 | $590K |
| Prednisone Generic | 41 | 58 | Under 11 | $204 |
| Omeprazole Generic | 39 | 58 | Under 11 | $414 |
| Acyclovir Generic | 37 | 53 | Under 11 | $465 |
| Ondansetron Odt Ondansetron | 23 | 23 | 19 | $260 |
| Revlimid Lenalidomide | 22 | 22 | Under 11 | $290K |
| Doxycycline Hyclate Generic | 21 | 23 | Under 11 | $235 |
| Eliquis Apixaban | 20 | 28 | Under 11 | $16K |
| Prochlorperazine Maleate Generic | 19 | 19 | 15 | $146 |
| Potassium Chloride Generic | 18 | 23 | Under 11 | $277 |
| Abiraterone Acetate Generic | 14 | 14 | Under 11 | $13K |
| Everolimus Generic | 13 | 13 | Under 11 | $5,533 |
| Dexamethasone Generic | 13 | 18 | Under 11 | $206 |
| Imatinib Mesylate Generic | 13 | 17 | Under 11 | $1,836 |
Brand drugs: 198 claims; generic drugs: 420 claims; opioid claims: 24.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Derek A Helton were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.